Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Contact the Center for Cancer Therapeutic Innovation

  • The Center for Cancer Therapeutic Innovation (CCTI) conducts phase I clinical trials for many types of solid tumor cancers. Patients and referring physicians are welcome to contact us for more information about current phase I clinical trials for cancer.

    If you are a patient interested in finding out more about phase I trials, please contact us using this secure online form, by calling 617-632-3332, via email at cctireferral@dfci.harvard.edu, or by fax at 617-632-2630.

    If you are a physician interested in referring a patient to a phase I trial, please contact us using this secure online form, by calling 617-632-3332, via email at cctireferral@dfci.harvard.edu, or by fax at 617-632-2630.

    CCTI New Patient Coordinator: cctireferral@dfci.harvard.edu

    CCTI nursing contact: cctireferral@dfci.harvard.edu

    Mailing address:

    Center for Cancer Therapeutic Innovation
    Dana-Farber Cancer Institute
    450 Brookline Avenue, Yawkey 6
    Boston, MA 02215

  • New Patient Appointments
    877-442-3324

    Make Appointment Online
    Dana-Farber/Brigham and Women's Cencer Center logo
    US News adult badge - smaller

  • Clinical Trials Questions?

    877-DF-TRIAL
    (877-338-7425)